IL1B and cancer: Increased levels of IL-1β accompany a vast number of inflammatory and non-inflammatory diseases and pathological states such as Alzheimer’s disease, cancer or rheumatoid arthritis (RA) (Mrak and Griffin, 2000; Lewis et al., 2006; Lo Gullo et al., 2014; Ruscitti et al., 2015).